Perrigo (PRGO) Other Working Capital Changes (2013 - 2026)
Perrigo (PRGO) posted quarterly Other Working Capital Changes of -$3.2 million for Q1 2026, down 150.0% year-over-year from $6.4 million in Q1 2025, and down 128.57% quarter-over-quarter from -$1.4 million in Q4 2025.
Perrigo (PRGO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Other Working Capital Changes for 14 consecutive years, with -$3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 150.0% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$35.8 million (down 1888.89% YoY), while the FY2025 annual figure was -$26.2 million, down 2.34% from the prior year.
- Other Working Capital Changes eased to -$3.2 million in Q1 2026 per PRGO's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $196.3 million in Q1 2026 and bottomed at -$228.2 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged $12.3 million across 5 years, with a median of $11.7 million in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 6900.0% in 2023 and fell as far as 757.32% in 2023.
- Perrigo's Other Working Capital Changes stood at $7.8 million in 2022, then sank by 191.03% to -$7.1 million in 2023, then surged by 36.62% to -$4.5 million in 2024, then soared by 68.89% to -$1.4 million in 2025, then slumped by 128.57% to -$3.2 million in 2026.
- Business Quant data shows PRGO's Other Working Capital Changes at -$3.2 million in Q1 2026, -$1.4 million in Q4 2025, and -$15.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -36.00 Mn |
| Jun 27, 2026 | -36.00 Mn |
| Jun 27, 2026 | -36.00 Mn |
| Mar 28, 2026 | 196.30 Mn |
| Mar 28, 2026 | 196.30 Mn |
| Mar 28, 2026 | 196.30 Mn |
| Dec 31, 2025 | 114.70 Mn |
| Dec 31, 2025 | 114.70 Mn |
| Dec 31, 2025 | 114.70 Mn |
| Sep 27, 2025 | -228.20 Mn |
| Sep 27, 2025 | -228.20 Mn |
| Sep 27, 2025 | -228.20 Mn |
| Jun 28, 2025 | 35.20 Mn |
| Jun 28, 2025 | 35.20 Mn |
| Jun 28, 2025 | 35.20 Mn |
| Mar 29, 2025 | 179.40 Mn |
| Mar 29, 2025 | 179.40 Mn |
| Mar 29, 2025 | 179.40 Mn |
| Dec 31, 2024 | -19.60 Mn |
| Dec 31, 2024 | -19.60 Mn |